These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Zhang JM, Cowell JL, Steven AC, Manclark CR. Dev Biol Stand; 1985 Sep; 61():173-85. PubMed ID: 2872103 [Abstract] [Full Text] [Related]
10. Separation and purification of the hemagglutinins from Bordetella pertussis. Sato Y, Cowell JL, Sato H, Burstyn DG, Manclark CR. Infect Immun; 1983 Jul; 41(1):313-20. PubMed ID: 6305841 [Abstract] [Full Text] [Related]
11. Purification and characterisation of a fimbrial haemagglutinin from Bordetella pertussis for use in an enzyme-linked immunosorbent assay. Askelöf P, Granström M, Gillenius P, Lindberg AA. J Med Microbiol; 1982 Feb; 15(1):73-83. PubMed ID: 6292428 [Abstract] [Full Text] [Related]
12. Purification and characterization of fimbriae isolated from Bordetella pertussis. Zhang JM, Cowell JL, Steven AC, Carter PH, McGrath PP, Manclark CR. Infect Immun; 1985 May; 48(2):422-7. PubMed ID: 2859248 [Abstract] [Full Text] [Related]
13. Serologic diagnosis of whooping cough by an enzyme-linked immunosorbent assay using fimbrial hemagglutinin as antigen. Granström M, Granström G, Lindfors A, Askelöf P. J Infect Dis; 1982 Dec; 146(6):741-5. PubMed ID: 6128367 [Abstract] [Full Text] [Related]
15. Fimbrial typing of Bordetella pertussis isolates: agglutination with polyclonal and monoclonal antibodies. Xing DK, Ramakrishnan S, Newland P, Corbel MJ. J Clin Microbiol; 2001 Nov; 39(11):4220. PubMed ID: 11712516 [No Abstract] [Full Text] [Related]
16. Comparison of type 2 and type 6 fimbriae of Bordetella pertussis by using agglutinating monoclonal antibodies. Li ZM, Brennan MJ, David JL, Carter PH, Cowell JL, Manclark CR. Infect Immun; 1988 Dec; 56(12):3184-8. PubMed ID: 2903125 [Abstract] [Full Text] [Related]
18. Preparation of filamentous hemagglutinin from Bordetella pertussis and assay for serum antibodies to filamentous hemagglutinin and pertussis toxin for clinical and public health laboratories. Wong KH, Skelton SK. J Clin Microbiol; 1989 Dec; 27(12):2805-10. PubMed ID: 2556434 [Abstract] [Full Text] [Related]
19. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis. Morokuma K, Ginnaga A, Nishihara T, Tsunoda S, Furukawa M, Aihara K, Sakoh M. Dev Biol Stand; 1991 Dec; 73():223-32. PubMed ID: 1685713 [Abstract] [Full Text] [Related]
20. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine. Thomas MG, Ashworth LA, Miller E, Lambert HP. J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651 [Abstract] [Full Text] [Related] Page: [Next] [New Search]